期刊文献+

Expression of OPGmRNA and ODFmRNA in the patients of hip fracture due to osteoporosis 被引量:2

Expression of OPGmRNA and ODFmRNA in the patients of hip fracture due to osteoporosis
下载PDF
导出
摘要 Objective:To investigate the gene expression of osteoprotegerin(OPG) and osteoclast differentiation factor(ODF) in the bone tissue of patients with hip fracture due to osteoporosis. Methods:OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers(over 50 years old) with hip fracture(Observer Group) and 30 cases of hip facture sufferers with no osteoporosis(Control group) were analyzed with the Semi-Quantitative RT-PCR method. Results:The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion:Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption. Objective:To investigate the gene expression of osteoprotegerin(OPG) and osteoclast differentiation factor(ODF) in the bone tissue of patients with hip fracture due to osteoporosis. Methods:OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers(over 50 years old) with hip fracture(Observer Group) and 30 cases of hip facture sufferers with no osteoporosis(Control group) were analyzed with the Semi-Quantitative RT-PCR method. Results:The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion:Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.
出处 《Journal of Nanjing Medical University》 2007年第5期321-323,共3页 南京医科大学学报(英文版)
关键词 OSTEOPOROSIS FRACTURE OSTEOPROTEGERIN osteoclast differentiation factor osteoporosis fracture osteoprotegerin osteoclast differentiation factor
  • 相关文献

参考文献11

  • 1柳林,董砚虎,司元国,曲宁.雌激素受体基因多态性与2型糖尿病骨量的关系[J].中国骨质疏松杂志,2004,10(4):466-470. 被引量:3
  • 2Yasuda H,Shima N,Nakagawa N,Mochizuki Sl,Yano K,Fujise N,et al.Identity of osteoclastotenesis inhibitory factor (OCIF) and osteoprotegerin (OPG):a mechanism by which OPG/OCIF inhib- its osteoclastogenesis in vitro[].The Journal of Endocrinology.1998
  • 3Huang L,Xu J,Wood DJ.Gene expression of osteoprotegerin ligand, osteoprotegerin,and receptor activator of NF-kappa B in giant cell tumor of hone:possible involvement in tumor cell-induced osteo- clast-like cell formation[].American Journal of Pathology.2000
  • 4Lin H,Jiake X,David JW.Gene expression of osteoprotegerin ligand,osteoprotegerin ligand receptor activator of NF-κB on giant cell tumor of bone[].American Journal of Pathology.2000
  • 5Matsuzaki K,Udagawa N,Takahashi N.Osteoclast differentiation factor(ODF) induces osteoclast like cell formation in human pe- ripheral blood mononuclear cell cultures[].Biochemical and Biophysical Research Communications.1998
  • 6Tsuda E,Goto M,Mochizuki S I et al.Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis[].Biochemical and Biophysical Research Communications.1997
  • 7Lacey DL,Timms E,Tan HL,et al.Osteoprotegerin Ligand is a cytokine that regulates osteoclast differentiation and activation[].Cell.1998
  • 8Simonet WS,Lacey DC,Dunstan CR,et al.a novel secreted protein involved in the regulation of bone density[].Cell.1997
  • 9AKATSU T,MURAKAMI T,NISHIKAWA M,et al.Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast[].Biochemical and Biophysical Research Communications.1998
  • 10LIU Lin,DONG Yanhu,SI Yuanguo,et al. Department of Endocrinology,Weifang People’s Hospital,Weifang 261041,China.Relationship between polymorphism of ER gene and bone mass in type 2 diabetes mellitus[].Chinese Journal of Osteoporosis.2004

二级参考文献8

  • 1胡迂芬,赵熙和,白锦,林英.膳食因素与妇女骨密度关系的研究[J].中国骨质疏松杂志,1998,4(2):27-30. 被引量:35
  • 2[1]Kobayashi S, Inous S, Hosoi T, et al. Association of bone mineral density with the polymorphism of estrogen receptor gene. J Bone Miner Res,1996, 11:306-311.
  • 3[2]Bagger YZ, Jorgensen HL, Heegaard AM, et al. No major effect of estrogen receptor gene polymorphism on bone mineral density or bone loss in postmenopausal Danish women. Bone, 2000,26:111-116.
  • 4[3]Giguere Y, RousseauF. The genetics of osteoporosis: complexities and difficulties. Clin Genet, 2000,57:161-169.
  • 5[4]Lau EM, Young RP, Lam V, et al. Estrogen receptor gene polymorphisms and bone mineral density in postmenopausal Chinese women. Bone,20001,29:96-98.
  • 6[8]Thomas DM, Ng KM, Best JD. Insulin and bone: a clinical scientific reviev. Endocrinol Metab , 1997,4:5-17.
  • 7[9]Willing M, Sowers M, Aron D,et al. Bone mineral density and its change in white women:estrogen and vitamin D receptor genetypes and their interaction. J Bone Miner Res, 1998,13:695-705.
  • 8车琦,周智广.糖尿病的骨量改变及其机理[J].中国糖尿病杂志,1998,6(3):171-173. 被引量:30

共引文献2

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部